Late onset adrenal hyperplasia: mutation at codon 282 of the functional 21-hydroxylase gene is not ubiquitous.
Ten patients affected with 21-hydroxylase (21-OH) deficient late-onset adrenal hyperplasia were studied to determine the prevalence of a mutation at codon 281 of the functional 21-OH gene (CYP21B) that results in a valine to leucine amino acid shift. This mutation has been reported in eight unrelated late-onset adrenal hyperplasia patients of Ashkenazi Jewish descent possessing the human leukocyte antigen-B14,DR1 haplotype. Normally, there are two 21-OH genes; a pseudogene (CYP21A) and a functional gene (CYP21B). The aberrant codon 281 sequence is normally present only in CYP21A. In all of our late-onset adrenal hyperplasia patients, hybridization of an oligonucleotide probe specific for this mutation was demonstrated to CYP21A but not to CYP21B. The mutation at codon 281 of CYP21B does not appear to be a ubiquitous genetic marker for 21-OH deficient late-onset adrenal hyperplasia, suggesting that this disorder may demonstrate the same molecular heterogeneity as congenital adrenal hyperplasia.
Wells
G
G
Department of Obstetrics and Gynecology, University of Alabama, Birmingham 35924.
Azziz
R
R
D000311:Adrenal Glands / Q000201:enzymology / Q000473:pathology*; D003062:Codon / Q000235:genetics; D005260:Female; D005787:Gene Frequency / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology; D006801:Humans; D006965:Hyperplasia / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D008297:Male; D009154:Mutation / Q000235:genetics; D009693:Nucleic Acid Hybridization; D015345:Oligonucleotide Probes; D015995:Prevalence; D015183:Restriction Mapping; D013255:Steroid 21-Hydroxylase / Q000187:drug effects / Q000235:genetics*
D003062:Codon; D005819:Genetic Markers; D006680:HLA Antigens; D015345:Oligonucleotide Probes; D013255:Steroid 21-Hydroxylase